Objective:
To evaluate the association between hematopoietic loss of the X chromosome (LOX) and natural conception in women, specifically focusing on its implications for reproductive aging.
Key Findings:
- Higher LOX levels were found in infertile women compared to controls, significant after adjusting for age, BMI, and prior pregnancy.
- A LOX threshold of 0.87% indicated more than twofold odds of not achieving natural conception, highlighting its potential as a predictive marker.
- The association was strongest in women aged 35 to 39 years.
- LOX was not associated with outcomes of assisted reproductive technology, indicating its specificity to natural conception.
- LOX did not correlate with serum AMH or FSH levels, suggesting it reflects a distinct biological dimension.
Interpretation:
LOX may reflect a biological dimension of reproductive aging distinct from traditional ovarian reserve markers, potentially indicating systemic genomic instability or immune dysregulation, warranting further exploration.
Limitations:
- Case-control design limits causality inference.
- Study relied on peripheral blood rather than reproductive tissue.
- Participants were exclusively Asian, limiting generalizability.
- Most controls were sampled during pregnancy, which may affect leukocyte dynamics.
- The infertility cohort included heterogeneous causes of reduced fertility.
Conclusion:
Hematopoietic LOX may provide complementary information to conventional ovarian reserve markers, warranting further prospective studies to evaluate its role in fertility risk stratification among younger women.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.